Subcutaneous Lenacapavir in People With Multidrug-Resistant HIV-1: 156 Week Results of the CAPELLA Study
Year: 2025
Type: article
Language: en
Topic: HIV/AIDS drug development and treatment
Authors and affiliations:
raw_author_name: Onyema Ogbuagu
raw_affiliation_strings: Department of Internal Medicine, Yale School of Medicine , New Haven, Connecticut ,
Yale School of Medicine, New Haven, Connecticut, USA
raw_author_name: Andrew Wiznia
raw_affiliation_strings: Jacobi Medical Center, Albert Einstein College of Medicine , Bronx, New York ,
Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA
raw_author_name: Joseph P McGowan
raw_affiliation_strings: Center for AIDS Research and Treatment, Northwell Health , Manhasset, New York ,
Center for AIDS Research and Treatment, Northwell Health, Manhasset, New York, USA
raw_author_name: Daniel S Berger
raw_affiliation_strings: Northstar Healthcare , Chicago, Illinois ,
Northstar Healthcare, Chicago, Illinois, USA
raw_author_name: Catherine M Creticos
raw_affiliation_strings: Howard Brown Health , Chicago, Illinois ,
Howard Brown Health, Chicago, Illinois, USA
raw_author_name: Debbie Hagins
raw_affiliation_strings: Coastal District Care Clinic , Savannah, Georgia ,
Coastal District Care Clinic, Savannah, Georgia, USA
raw_author_name: Theo Hodge
raw_affiliation_strings: Washington Health Institute , Washington, District of Columbia ,
Washington Health Institute, Washington, District of Columbia, USA
raw_author_name: Olayemi Osiyemi
raw_affiliation_strings: Triple O Research Institute PA , West Palm Beach, Florida ,
Triple O Research Institute PA, West Palm Beach, Florida, USA
raw_author_name: James Sims
raw_affiliation_strings: St Hope Foundation , Houston, Texas ,
St Hope Foundation, Houston, Texas, USA
raw_author_name: David A Wheeler
raw_affiliation_strings: Infectious Diseases Physicians, Inc. , Annandale, Virginia ,
Infectious Diseases Physicians, Inc., Annandale, Virginia, USA
raw_author_name: Hui Wang
raw_affiliation_strings: Gilead Sciences, Inc. , Foster City, California ,
Gilead Sciences, Inc., Foster City, California, USA
raw_author_name: Nicolas A Margot
raw_affiliation_strings: Gilead Sciences, Inc. , Foster City, California ,
Gilead Sciences, Inc., Foster City, California, USA
raw_author_name: Hadas Dvory-Sobol
raw_affiliation_strings: Gilead Sciences, Inc. , Foster City, California ,
Gilead Sciences, Inc., Foster City, California, USA
raw_author_name: Martin S Rhee
raw_affiliation_strings: Gilead Sciences, Inc. , Foster City, California ,
Gilead Sciences, Inc., Foster City, California, USA
raw_author_name: Sorana Segal-Maurer
raw_affiliation_strings: Division of Infectious Diseases, New York-Presbyterian Queens , Flushing, New York ,
Division of Infectious Diseases, New York-Presbyterian Queens, Flushing, New York, USA
raw_author_name: Jean-Michel Molina
raw_affiliation_strings: Department of Infectious Diseases, Université de Paris Cité, Saint-Louis and Lariboisière Hospitals, APHP , Paris ,
INSERM 1342, Université Paris Cité, 1 Ave Claude Vellefaux, Paris 75010 ,
Université de Paris Cité, Department of Infectious Diseases, Saint-Louis and Lariboisière Hospitals, APHP , Paris, France and INSERM 1342